Literature & Media

​New Drug Monograph: ADB-5'Br-BINACA (ADB-5'Br-BUTINACA)

Monographs


New synthetic cannabinoids continue to emerge in the recreational drug supply following the class-wide ban implemented by China in July 2021. This NPS Discovery Monograph documents the newly identified synthetic cannabinoid ADB-5'Br-BINACA (ADB-5'Br-BUTINACA) containing a brominated indazole core, confirmed using Cayman's reference standard. To avoid confusion with tail substituents, Cayman and the CFSRE have developed a revised naming convention for new synthetic cannabinoids containing core substituents, denoted by a prime (‘) designation placed in the middle of the name.

Download Copy (PDF)
<p>​New Drug Monograph&#58;&#160;ADB-5'Br-BINACA (ADB-5'Br-BUTINACA)<br></p>
Cayman ChemicalCayman ChemicalCayman Chemical

Receive Our News & Literature Directly to Your Inbox!

Log in or register to subscribe to our email list. You will receive emails packed with new products and content that match your research interests. We only email once a week and you can unsubscribe at any time.